Revenue plummeted to $477.0K in 2026Q1, reflecting a 91.2% year-over-year contraction alongside a negative gross margin of -2.2% that underscores significant scaling difficulties.
| Sales/Revenue | 13.97M | 18.92M | 31.28M | 28.8M | 0 | 0 | 0 | 0 |
| Revenue Growth % | -53.26% | -39.51% | 8.6% | - | - | - | - | - |
| Cost of Goods Sold | 14.59M | 18.38M | 30.86M | 23.59M | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | 97.14% | 98.66% | 81.9% | - | - | - | - |
| Gross Profit | -617K | 541K | 418K | 5.21M | 0 | 0 | 0 | 0 |
| Gross Margin % | -4.42% | 2.86% | 1.34% | 18.1% | - | - | - | - |
| Gross Profit Growth % | - | 29.43% | -91.98% | - | - | - | - | - |
| Operating Expenses | 63.55M | 64M | 85.28M | 60.1M | 38.95M | 26.93M | -11.18M | -11.06M |
| OpEx % of Revenue | - | 338.22% | 272.62% | 208.63% | - | - | - | - |
| Selling, General & Admin | 41.67M | 39.07M | 40.77M | 35.38M | 24.09M | 17.27M | 6.56M | 3.71M |
| SG&A % of Revenue | - | 206.5% | 130.32% | 122.83% | - | - | - | - |
| Research & Development | 13.21M | 13.75M | 18.55M | 21.35M | 14.14M | 9.12M | 4.14M | 6.7M |
| R&D % of Revenue | - | 72.66% | 59.31% | 74.12% | - | - | - | - |
| Other Operating Expenses | 3M | 11.18M | 25.96M | 3.36M | 711K | 544K | -21.88M | -21.47M |
| Operating Income | -64.17M | -63.46M | -84.86M | -54.88M | -38.95M | -26.93M | 11.18M | 11.06M |
| Operating Margin % | -459.34% | -335.36% | -271.28% | -190.53% | - | - | - | - |
| Operating Income Growth % | - | 25.22% | -54.63% | -40.91% | -44.61% | -340.9% | 1.12% | - |
| EBITDA | -54.52M | -52.28M | -74.15M | -51.52M | -37.65M | -26.11M | 11.66M | 11.7M |
| EBITDA Margin % | -390.29% | -276.3% | -237.03% | -178.85% | - | - | - | - |
| EBITDA Growth % | 38.03% | 29.49% | -43.92% | -36.82% | -44.22% | -323.94% | -0.37% | - |
| D&A (Non-Cash Add-back) | 9.65M | 11.18M | 10.71M | 3.36M | 1.29M | 824K | 479K | 645.76K |
| EBIT | -239.13M | -248.95M | -82.66M | 22.84M | 78.57M | 44.93M | -11.18M | -11.06M |
| Net Interest Income | 520K | -123K | -371K | 6.17M | 8.82M | -1.43M | 0 | 51.59K |
| Interest Income | 611K | 0 | 0 | 6.3M | 8.82M | 1.41M | 341K | 51.59K |
| Interest Expense | 91K | 123K | 371K | 131K | 0 | 2.84M | 341K | 0 |
| Other Income/Expense | -176.18M | -185.62M | 1.83M | 77.59M | 117.52M | 69.02M | -41.48M | -11.54M |
| Pretax Income | -240.34M | -249.08M | -83.03M | 22.71M | 78.57M | 42.09M | -30.3M | -479.41K |
| Pretax Margin % | -1720.56% | -1316.34% | -265.42% | 78.84% | - | - | - | - |
| Income Tax | 562K | 621K | 669K | -1.09M | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | -0.23% | -0.25% | -0.81% | -4.79% | 0% | 0% | 0% | 0% |
| Net Income | -240.91M | -249.7M | -83.7M | 23.8M | 78.57M | 42.09M | -30.3M | -479.41K |
| Net Margin % | -1724.58% | -1319.62% | -267.56% | 82.62% | - | - | - | - |
| Net Income Growth % | -150.36% | -198.34% | -451.7% | -69.71% | 86.67% | 238.9% | -6220.7% | - |
| Net Income (Continuing) | -240.91M | -249.7M | -83.7M | 23.8M | 78.57M | 42.09M | -30.3M | -479.41K |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -44.80 | -50.55 | -17.54 | 5.00 | 16.58 | 11.89 | -14.53 | -0.33 |
| EPS Growth % | -138.5% | -188.2% | -450.8% | -69.84% | 39.44% | 181.83% | -4263.36% | - |
| EPS (Basic) | - | -50.55 | -17.54 | 5.11 | 17.13 | 12.47 | -14.53 | -0.33 |
| Diluted Shares Outstanding | 5.38M | 4.94M | 4.77M | 4.76M | 4.74M | 3.54M | 2.08M | 1.28M |
| Basic Shares Outstanding | 5.38M | 4.94M | 4.77M | 4.66M | 4.59M | 3.37M | 2.08M | 1.28M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - |
Capital exhaustion and dilution
As reported in recent financial filings, Origin Materials experienced a severe revenue decline, with quarterly figures plummeting to $477.0K in 2026Q1, representing a staggering 91.2% year-over-year contraction that underscores the instability of its current project-based and transitional business model compared to previous periods.
The sharp drop in top-line performance suggests that the company's reliance on limited product shipments and joint development agreements has failed to provide a reliable growth floor. Investors should monitor whether the pivot toward the 'Caps and Closures' segment can generate sufficient volume to reverse this downward trajectory or if the revenue base remains fundamentally fragile.
Based on the company's latest income statement, gross margins have remained consistently thin or negative, reaching a dismal -2.2% in 2026Q1, which highlights the significant difficulty in achieving the necessary economies of scale for its biomass conversion technology.
The inability to maintain positive gross margins suggests that the cost of feedstock and chemical processing currently outweighs the value proposition of the end products. This structural margin deficit implies that the company is far from achieving the operational efficiency required to compete with traditional, oil-based chemical producers.
According to the provided quarterly data, the company's operating margin of -34.6% in 2026Q1 demonstrates a lack of operating leverage, as SG&A expenses continue to dwarf gross profit, leaving the firm unable to scale its operations effectively without incurring substantial losses.
The persistent gap between operating expenses and gross profit indicates that the company's overhead structure is misaligned with its current revenue generation capacity. This suggests that management's efforts to control costs have not yet offset the high fixed-cost burden associated with its capital-intensive chemical processing infrastructure.
Financial statements reveal that the company's cost structure is dominated by heavy R&D and SG&A spending, with SG&A alone reaching $12.7 million in 2026Q1, significantly exceeding the total revenue generated during the same period, which warrants further investigation into expense discipline.
The high level of recurring SG&A and R&D expenses relative to revenue suggests that the company is maintaining a significant corporate footprint despite the lack of commercial-scale output. This cost structure appears to be a major drag on liquidity and may necessitate further capital raises if revenue does not scale rapidly.
Based on the reported cash position of approximately $32.9 million and ongoing quarterly operating losses, the company faces a precarious financial situation that may force dilutive equity financing or debt issuance to sustain operations, as indicated by the recent trend in net income.
Short-sellers would likely focus on the mismatch between the company's ambitious technology roadmap and its rapidly depleting cash reserves. The lack of a clear path to self-sustaining cash flow suggests that the current valuation may be vulnerable to significant downward pressure if capital market access tightens.
Quick answers to the most common questions about buying ORGN stock.
For fiscal year 2025, Origin Materials, Inc. (ORGN) reported total revenue of $18.9M.
Origin Materials, Inc. (ORGN) reported a net loss of $249.7M for the fiscal year ending 2025.
Origin Materials, Inc. (ORGN) reported an operating income of $-63.5M, resulting in an operating profit margin of -335.4%. This margin reflects the operational efficiency of the business before interest and taxes.
Origin Materials, Inc. (ORGN) generated $0.5M in gross profit for the year, representing a gross profit margin of 2.9%. This demonstrates the company's core pricing power and production efficiency.